Rythmodan P

Rythmodan P Brand names, Rythmodan P Analogs

Rythmodan P Brand Names Mixture

No information avaliable

Rythmodan P Chemical_Formula

C₂₁H₂₉N₃O

Rythmodan P RX_link

http://www.rxlist.com/cgi/generic2/disopyr.htm

Rythmodan P fda sheet

Rythmodan P msds (material safety sheet)

Rythmodan P Synthesis Reference

No information avaliable

Rythmodan P Molecular Weight

339.475 g/mol

Rythmodan P Melting Point

94.5-95 ^oC

Rythmodan P H₂O Solubility

44.9 mg/L

Rythmodan P State

Solid

Rythmodan P LogP

3.972

Rythmodan P Dosage Forms

Capsule; Tablet (extended-release)

Rythmodan P Indication

For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias.

Rythmodan P Pharmacology

Disopyramide is an antiarrhythmic drug indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia that are life-threatening. In man, Disopyramide at therapeutic plasma levels shortens the sinus node recovery time, lengthens the effective refractory period of the atrium, and has a minimal effect on the effective refractory period of the AV node. Little effect has been shown on AV-nodal and His-Purkinje conduction times or QRS duration. However, prolongation of conduction in accessory pathways occurs.

Rythmodan P Absorption

Nearly complete

Rythmodan P side effects and Toxicity

LD₅₀=580 mg/kg in rats

Rythmodan P Patient Information